BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2369647)

  • 1. Whole complement hemolytic activity (CH50) following infusion of stroma-free and polyhemoglobin solutions in rats.
    Ning J; Chang TM
    Biomater Artif Cells Artif Organs; 1990; 18(2):203-17. PubMed ID: 2369647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of homologous and heterologous stroma-free hemoglobin and polyhemoglobin on complement activation, leucocytes and platelets.
    Ning J; Chang TM
    Biomater Artif Cells Artif Organs; 1990; 18(2):219-32. PubMed ID: 2369648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronotropic effects of in vitro perfusion with albumin, stroma-free hemoglobin, and polyhemoglobin solutions.
    Walter SV; Chang TM
    Biomater Artif Cells Artif Organs; 1990; 18(2):283-98. PubMed ID: 2369651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effects of stroma-free hemoglobin and polyhemoglobin on coagulation factors in rats.
    Ning J; Chang TM
    Int J Artif Organs; 1990 Aug; 13(8):509-16. PubMed ID: 2228294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunological properties of stroma-free polyhemolysate containing catalase and superoxide dismutase activities prepared by polymerized bovine stroma-free hemolysate.
    Zhu H; Du Q; Chen C; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2010 Apr; 38(2):57-63. PubMed ID: 20205612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of honey on 50% complement hemolytic activity in infants with protein energy malnutrition: a randomized controlled pilot study.
    Abdulrhman MA; Nassar MF; Mostafa HW; El-Khayat ZA; Abu El Naga MW
    J Med Food; 2011 May; 14(5):551-5. PubMed ID: 21186977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-linked stroma-free polyhemoglobin as a potential blood substitute.
    Keipert P; Minkowitz J; Chang TM
    Int J Artif Organs; 1982 Nov; 5(6):383-5. PubMed ID: 7160935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sheep Erythrocyte Preparation for Hemolytic Tests Exploring Complement Functional Activities.
    Chabannes M; Bordereau P; Martins PV; Dragon-Durey MA
    Methods Mol Biol; 2021; 2227():61-67. PubMed ID: 33847931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ephedra sinica inhibits complement activation and improves the motor functions after spinal cord injury in rats.
    Li L; Li J; Zhu Y; Fan G
    Brain Res Bull; 2009 Mar; 78(4-5):261-6. PubMed ID: 19000748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pyridoxalated polyhemoglobin and stroma-free hemoglobin on ADP-induced platelet aggregation.
    Lalla FR; Ning J; Chang TM
    Biomater Artif Cells Artif Organs; 1989; 17(3):363-9. PubMed ID: 2819260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a single replacement of one of Ringer lactate, hypertonic saline/dextran, 7g% albumin, stroma-free hemoglobin, o-raffinose polyhemoglobin or whole blood on the long term survival of unanesthetized rats with lethal hemorrhagic shock after 67% acute blood loss.
    Chang TM; Varma R
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):503-10. PubMed ID: 1391471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preclinical screening test for modified hemoglobin to bridge the gap between animal safety studies and use in human.
    Chang TM; Lister C
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):565-73. PubMed ID: 1391479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation and the toxicity of stroma-free hemoglobin solutions in primates.
    Feola M; Simoni J; Dobke M; Canizaro PC
    Circ Shock; 1988 Aug; 25(4):275-90. PubMed ID: 3168173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plasma levels of complement in patients with acute ischemic stroke.
    Cojocaru IM; Cojocaru M; Tănăsescu R; Burcin C; Atanasiu AN; Petrescu AM; Mitu AC; Iliescu I; Dumitrescu L
    Rom J Intern Med; 2008; 46(1):77-80. PubMed ID: 19157274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects on the amount of total hemolytic complement levels(CH50) and immunoglobulin in serum induced by the implantation of biomaterials into rats].
    Zhu M; Zeng Y; Jiang L; Huang P; Wu Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1999 Sep; 16(3):275-8. PubMed ID: 12552743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antibody titers in rats receiving repeated small subcutaneous injections of hemoglobin or polyhemoglobin: a preliminary report.
    Hertzman CM; Keipert PE; Chang TM
    Int J Artif Organs; 1986 May; 9(3):179-82. PubMed ID: 3733244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects on the histology and function of livers and spleens in rats after 33% toploading of PEG-PLA-nano artificial red blood cells.
    Liu ZC; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(6):513-24. PubMed ID: 19043818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of serum or buffer-changed EDTA-plasma in a rapid, inexpensive, and easy-to-perform hemolytic complement assay for differential diagnosis of systemic lupus erythematosus and monitoring of patients with the disease.
    Ekdahl KN; Norberg D; Bengtsson AA; Sturfelt G; Nilsson UR; Nilsson B
    Clin Vaccine Immunol; 2007 May; 14(5):549-55. PubMed ID: 17344343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-assisted linearization of the von Krogh Curve for the measurement of serum complement titre.
    Kamiyama M; Kamiyama E; Arkel YS
    Clin Lab Haematol; 1990; 12(3):345-9. PubMed ID: 2272162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation and thromboxane secretion by liposome-encapsulated hemoglobin in rats in vivo: inhibition by soluble complement receptor type 1.
    Szebeni J; Spielberg H; Cliff RO; Wassef NM; Rudolph AS; Alving CR
    Artif Cells Blood Substit Immobil Biotechnol; 1997 Jul; 25(4):347-55. PubMed ID: 9242930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.